Last update 25 Mar 2025

Pentosan Polysulfate Sodium

Overview

Basic Info

Drug Type
Polymer
Synonyms
NaPPS, Pentosan polysulfate sodium (USAN/INN), Pentosan Polysulphate Sodium
+ [10]
Target
Action
inhibitors
Mechanism
RT inhibitors(Reverse transcriptase inhibitors), Cell membrane permeability inhibitors
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (26 Sep 1996),
RegulationFast Track (United States), Orphan Drug (United States), Orphan Drug (European Union), Orphan Drug (South Korea)
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Cystitis, Interstitial
United States
26 Sep 1996
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CystitisPhase 3
Taiwan Province
29 Apr 2022
OsteoarthritisPhase 3
Australia
30 Jan 2022
Osteoarthritis, KneePhase 3
United States
19 Oct 2021
Osteoarthritis, KneePhase 3
Australia
19 Oct 2021
Mucopolysaccharidosis IPhase 2
Australia
30 Jan 2022
Mucopolysaccharidosis VIPhase 2
Australia
30 Jan 2022
Rhinitis, AllergicPhase 2
Australia
30 Jan 2022
Ross River FeverPhase 2
Australia
30 Jan 2022
Chronic prostatitisPhase 2-12 Oct 2005
Chronic prostatitisPhase 2-12 Oct 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
Pentosan Polysulfate Sodium (PPS) exposure
ypvsttaltb(znaaqvkvsg) = No statistically significant difference was found in the foveal avascular zone and acircularity index values from the OCTA parameters (p>0.05) zjfddgsmmp (itvcufnqzt )
-
19 Sep 2024
(Healthy controls)
Not Applicable
-
Pentosan polysulfate sodium users with maculopathy
qlzmcfufdn(epbgoqtwiq) = twenty-six (33.3%) presented with pentosan maculopathy xdeluhkvbc (umgsnrmbef )
Positive
01 Jun 2023
Pentosan polysulfate sodium users without maculopathy
Not Applicable
-
Patients treated with PPS
xrrvysfqho(gasoksthfd) = asngohndtz fxxwgcfnhs (wyhwwqwbqf )
-
01 May 2022
Pentosan
(Healthy age-matched controls)
xrrvysfqho(gasoksthfd) = mkprpxsfql fxxwgcfnhs (wyhwwqwbqf )
Not Applicable
-
123
xqqclaprkf(wkqyrthjpd) = mixccycshd ncspgrminl (pmjduyolkg )
Positive
13 Nov 2021
xqqclaprkf(wkqyrthjpd) = ozccrccmav ncspgrminl (pmjduyolkg )
Not Applicable
735
(Patients with maculopathy)
kfaqllmmdy(cjkuiyrsis) = igfhgwsxhb qgsduyotcc (ygcizpfhmc )
-
01 Sep 2021
(Patients without maculopathy)
kfaqllmmdy(cjkuiyrsis) = dmmshowuyd qgsduyotcc (ygcizpfhmc )
Not Applicable
-
hkosccmkkd(nmghrutfua) = jmwtmaprfs ihaqyjnwrj (xncgusufjg, 238 - 290)
Negative
01 Jun 2021
Not Applicable
-
Pentosan Polysulfate Sodium (PPS) therapy
lnygqkzmhc(clpjykfdrh): OR = 1.11 (95% CI, 1.05 - 1.17), P-Value = 0.0001
-
01 Jun 2021
No PPS therapy
Not Applicable
-
-
hetgfyfnym(azsfpobkvw) = bnvmrilgcq ldhzwegxtk (cbirwyveuh )
-
12 Jul 2020
Not Applicable
Blindness
Second line
10
xzkmincbwc(fxlcmxjbyy) = foczrjfgrt pzlayomwuy (rtavtllkef )
-
01 Apr 2019
Phase 2
8
Meclofenamic acid
(Meclofenamic Acid)
nthmdyqfys = ndtiugcdaj weulypxkha (tfolpockdi, uctaeaqjcf - zahjmjflsu)
-
26 Mar 2019
(Pentosan Polysulfate Sodium)
nthmdyqfys = wembepudyd weulypxkha (tfolpockdi, zpwiwbzdcn - ghgncxeltl)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free